Boston Scientific Corporation develops medical devices for various specialties worldwide. It operates through two segments: MedSurg and Cardiovascular. The company offers devices to diagnose and treat conditions such as gastrointestinal, pulmonary, urological, neurological movement disorders, chronic pain, coronary artery disease, aortic valve conditions, and cancer. Additionally, it provides technologies for diagnosing and treating cardiac abnormalities, rate and rhythm disorders, peripheral arterial and venous diseases. The company is headquartered in Marlborough, Massachusetts. It was incorporated in 1979.
| Indicator | Value |
|---|---|
| PER | 82.0 |
| EV/EBITDA | 37.3 |
| Price/Free Cash Flow' | 64.3 |
| ROIC | 10.6% |
| Net Debt/EBITDA | 2.3 |